|
NSMCE2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62069999998238E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.13749999999902E-06 |
| Normal-vs-Stage2 |
4.210600E-04 |
| Normal-vs-Stage3 |
1.051930E-02 |
| Normal-vs-Stage4 |
6.846700E-04 |
| Stage1-vs-Stage2 |
3.496600E-01 |
| Stage1-vs-Stage3 |
1.122830E-01 |
| Stage1-vs-Stage4 |
7.739600E-01 |
| Stage2-vs-Stage3 |
6.293900E-02 |
| Stage2-vs-Stage4 |
3.179600E-01 |
| Stage3-vs-Stage4 |
3.177000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.7437000000029E-06 |
| Normal-vs-AfricanAmerican |
6.742100E-03 |
| Normal-vs-Asian |
6.509700E-02 |
| Caucasian-vs-AfricanAmerican |
6.324600E-01 |
| Caucasian-vs-Asian |
1.330610E-01 |
| AfricanAmerican-vs-Asian |
7.757900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.03939999998681E-07 |
| Normal-vs-Female |
5.244400E-03 |
| Male-vs-Female |
8.895500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.416000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.66874999999456E-05 |
| Normal-vs-Age(61-80Yrs) |
1.024120E-04 |
| Normal-vs-Age(81-100Yrs) |
1.252020E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.551800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.041400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.848600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.868600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.504600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.070050E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.701900E-03 |
| Normal-vs-Grade 2 |
4.69239999967286E-07 |
| Normal-vs-Grade 3 |
1.603310E-04 |
| Normal-vs-Grade 4 |
8.516100E-02 |
| Grade 1-vs-Grade 2 |
4.781800E-01 |
| Grade 1-vs-Grade 3 |
1.579050E-01 |
| Grade 1-vs-Grade 4 |
5.224500E-02 |
| Grade 2-vs-Grade 3 |
1.949570E-01 |
| Grade 2-vs-Grade 4 |
3.959900E-02 |
| Grade 3-vs-Grade 4 |
2.634800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.35240000309622E-08 |
| Normal-vs-ccB subtype |
1.224280E-02 |
| ccA subtype-vs-ccB subtype |
3.320600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.43289999999341E-05 |
| Normal-vs-N1 |
8.646400E-01 |
| N0-vs-N1 |
7.436500E-04 |
|
|
